Client’s Goals

Our client, a key provider of hernia repair surgery, engaged MarketsandMarkets to increase revenues and identify growth opportunities. The client was keen on understanding growth avenues for hernia mesh fixation procedures utilizing glue & tack applicators. For this purpose, we defined and solved a series of problems. Our team offered insights on the interconnected ecosystem of our client’s clients and their clients. Two of the key questions answered during the engagement are:

• Insights into key country-level markets, such as the US, Canada, Germany, France, the UK, Spain, Italy, Japan, China, and India
• Understanding of the growth trends and future prospects for hernia mesh fixation and hernia mesh repair products

Our Approach

First of all, we identified the total number of hernia repair surgeries performed. The data was broken down into the number of procedures performed using tac, tac applicator, and glue. Country-level data was offered through our AI-driven market intelligence platform, KnowledgeStore. The data was further split into surgeries by biological mesh and synthetic mesh.

Our team also interviewed key service providers, vendors, and distributors to confirm the sales and the split of surgeries performed. Through this, our analysts were able to provide its client an in-depth understanding of the sales of hernia mesh repair products in each country: the US, Canada, Germany, France, the UK, Spain, Italy, Japan, China, and India. Further, we also helped the client obtain a better understanding of the number of open hernia repair and laparoscopic hernia repair surgeries using tac, tac applicator, and glue in each country.

Revenue Shifts Identified

Allografts and xenografts are increasingly being used across multiple clinical applications such as post-operative rehabilitation and hernia repair. Their rising adoption coupled with related developments in laparoscopic surgical procedures is expected to further drive the hernia mesh repair market.

Interconnections

Smart biomaterials are emerging class of biomaterials that are expected to deliver specific therapeutic agents to specific local site. This is poised to be further augmented by relevant disruptions in nanotechnology that is expected to further contribute to their demand growth with development of novel products.

Unknowns Identified

Drug loaded mesh and composite mesh are coated with specialized antibiotic coating; those are currently under development. These products are expected to disrupt the market once their clinical efficacy is established with credible research validation.

Revenue Impact (RI)

Our client services team helped the client to expand into USD 2.5 billion hernia mesh products market with an expected revenue growth of USD 125 million across target countries